Financial Statements · Financial Reporting
Pharma Nord Eesti OÜ
Official identifier 14194775Record date 31 Dec 2023
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2023
- Period start
- 1 Jan 2023
- Submitted date
- 24 Apr 2024
Report
- Consolidated
- No
- Audited
- No
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 364,550 |
| Balance sheet | Cash and cash equivalents | 67,132 |
| Balance sheet | Current assets | 359,805 |
| Balance sheet | Current liabilities | 288,151 |
| Balance sheet | Equity | 76,399 |
| Balance sheet | Share capital at nominal value | 2,500 |
| Balance sheet | Non-current assets | 4,745 |
| Balance sheet | Retained earnings (loss) from previous periods | 24,368 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -2,308 |
| Income statement scheme 1 | Labour costs | -246,436 |
| Income statement scheme 1 | Revenue | 700,869 |
| Income statement scheme 1 | Annual period profit / loss | 49,531 |
| Income statement scheme 1 | Operating profit (loss) | 49,531 |
| Income statement scheme 1 | Profit (loss) before income tax | 49,531 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 24,368 |
| Note: Labour costs | Employees | 7 |
| Note: Labour costs | Labour costs | 246,436 |
Linked company
Company: Pharma Nord Eesti OÜ